IRIS
BERGAMINI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.518
AS - Asia 687
NA - Nord America 513
SA - Sud America 60
OC - Oceania 10
AF - Africa 2
Totale 3.790
Salva come PNG Salva come JPEG
Nazione #
RO - Romania 1.748
US - Stati Uniti d'America 498
IT - Italia 288
CN - Cina 251
SG - Singapore 251
SE - Svezia 218
HK - Hong Kong 123
RU - Federazione Russa 118
BR - Brasile 50
DE - Germania 44
NL - Olanda 24
FI - Finlandia 20
IE - Irlanda 16
IN - India 13
AT - Austria 9
CA - Canada 9
FR - Francia 8
GB - Regno Unito 8
PK - Pakistan 7
AU - Australia 6
JP - Giappone 6
QA - Qatar 6
ID - Indonesia 5
AR - Argentina 4
BE - Belgio 4
IL - Israele 4
MX - Messico 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
TR - Turchia 4
IQ - Iraq 3
PE - Perù 3
PL - Polonia 3
CH - Svizzera 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.790
Salva come PNG Salva come JPEG
Città #
Shanghai 131
Hong Kong 123
Milan 101
Singapore 93
New York 58
Ashburn 54
Lawrence 46
Princeton 46
Moscow 36
Boardman 33
Vaprio d'Adda 25
Bergamo 23
Brescia 16
Dallas 16
Dublin 16
Helsinki 16
Nuremberg 13
Seattle 13
Rome 12
St Petersburg 12
Cesano Boscone 10
Los Angeles 10
Pune 10
Doha 6
Falkenstein 6
Guangzhou 6
São Paulo 6
Amsterdam 5
Dalmine 5
Florence 5
Gatchina 5
Shenzhen 5
Toronto 5
Turin 5
Xi'an 5
Yekaterinburg 5
Al Qatif 4
Beijing 4
Boston 4
Como 4
Lappeenranta 4
London 4
Munich 4
Pesaro 4
Azcapotzalco 3
Bandung 3
Brussels 3
Chapel Hill 3
Hadera 3
Lima 3
Lissone 3
Maarheeze 3
Meda 3
Noisy-le-Grand 3
Osimo 3
Peshawar 3
Philadelphia 3
Rio de Janeiro 3
Warsaw 3
Amman 2
Bari 2
Baronissi 2
Benevento 2
Borås 2
Burnaby 2
Cambridge 2
Castenaso 2
Fano 2
Fiesole 2
Fortaleza 2
Foshan 2
Francisco Santos 2
Genova 2
Higashihagoromo 2
Hyderabad 2
Inman 2
Innsbruck 2
Jiaxing 2
Jiyuan 2
Lambeth 2
Lanzhou 2
Linz 2
Los Banos 2
Lower Hutt 2
Madison 2
Malé 2
Manerbio 2
Melbourne 2
Naaldwijk 2
Nizhniy Novgorod 2
Ottawa 2
Paderno Franciacorta 2
Padova 2
Palo Alto 2
Pekalongan 2
Perm 2
Perugia 2
Quanzhou 2
Rockville 2
Roseto degli Abruzzi 2
Totale 1.141
Salva come PNG Salva come JPEG
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 302
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 294
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 291
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 286
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 285
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 283
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 182
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 121
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 68
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 58
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 54
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 49
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 48
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 41
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 36
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 36
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 34
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 33
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 33
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 32
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 32
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 32
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 31
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 31
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 31
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 30
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 29
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 28
Psychological aspects and fertility issues of GTD 28
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 28
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 27
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 27
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 27
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 27
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 26
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 26
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 25
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 25
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 25
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 24
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 24
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 24
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 23
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 23
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 23
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 23
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 22
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 22
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 22
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 22
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 21
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 21
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 20
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 20
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 20
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 19
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 19
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 19
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 19
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 19
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 18
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 18
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 17
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 17
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 17
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 17
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 16
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 16
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 16
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 16
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 16
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 16
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 16
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 16
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 15
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 15
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 15
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 15
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 14
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 14
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 14
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 14
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 13
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 12
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 12
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 12
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 12
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 11
Ovarian endometrioma: what the patient needs 11
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 11
Fertility preservation in women with cervical cancer 11
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 10
Totale 4.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202120 0 2 5 2 0 3 4 4 0 0 0 0
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20252.798 141 35 64 51 89 130 1.955 162 171 0 0 0
Totale 4.013